Literature DB >> 23236551

Acute myeloid leukemia with cryptic CBFB-MYH11 type D.

Takashi Kobayashi1, Motoshi Ichikawa, Yasuhiko Kamikubo, Mineo Kurokawa.   

Abstract

A 77 year-old female was found with FAB M4Eo acute myeloid leukemia. Although CBFB-MYH11 mRNA was detected in RT-PCR, the conventional cytogenetic analysis failed to reveal inv(16). Fluorescence in situ hybridization (FISH) and the sequence analysis revealed a fusion between the exon 5 of CBFB and the exon 8 of MYH11, resulting in a minor variant fusion product previously reported as type D. In order to detect the cryptic inv(16) type D, both FISH and RT-PCR are required, and furthermore, the primers for the sequence analysis needs to be selected for the proper diagnosis.

Entities:  

Keywords:  Acute myeloid leukemia; CBFB-MYH11; RT-PCR; fluorescence in situ hybridization; inversion 16

Mesh:

Substances:

Year:  2012        PMID: 23236551      PMCID: PMC3515980     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  10 in total

Review 1.  Variant three-way translocation of inversion 16 in AML-M4Eo confirmed by fluorescence in situ hybridization analysis.

Authors:  J A Martinez-Climent; A M Comes; E Vizcarra; S Reshmi; I Benet; I Marugan; M Tormo; M J Terol; C Solano; C Arbona; F Prosper; E Barragan; P Bolufer; J D Rowley; J García-Conde
Journal:  Cancer Genet Cytogenet       Date:  1999-04-15

2.  Molecular analysis of a new variant of the CBF beta-MYH11 gene fusion.

Authors:  Jennifer Stulberg; Suzanne Kamel-Reid; Kathy Chun; Jason Tokunaga; Richard A Wells
Journal:  Leuk Lymphoma       Date:  2002-10

3.  Characterization and use of an antibody detecting the CBFbeta-SMMHC fusion protein in inv(16)/t(16;16)-associated acute myeloid leukemias.

Authors:  D S Viswanatha; I Chen; P P Liu; M L Slovak; C Rankin; D R Head; C L Willman
Journal:  Blood       Date:  1998-03-15       Impact factor: 22.113

4.  Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association.

Authors:  M M Le Beau; R A Larson; M A Bitter; J W Vardiman; H M Golomb; J D Rowley
Journal:  N Engl J Med       Date:  1983-09-15       Impact factor: 91.245

5.  Detection of karyotypic aberrations in acute myeloblastic leukaemia: a prospective comparison between PCR/FISH and standard cytogenetics in 140 patients with de novo AML.

Authors:  J Krauter; W Peter; U Pascheberg; B Heinze; L Bergmann; D Hoelzer; M Lübbert; G Schlimok; R Arnold; H Kirchner; M Port; A Ganser; G Heil
Journal:  Br J Haematol       Date:  1998-10       Impact factor: 6.998

6.  Minimal residual disease quantification in patients with acute myeloid leukaemia and inv(16)/CBFB-MYH11 gene fusion.

Authors:  Bert A van der Reijden; Annet Simons; Erna Luiten; Sonja C van der Poel; Pauline E Hogenbirk; Evelyn Tönnissen; Peter J M Valk; Bob Löwenberg; Georgine E De Greef; Martijn H Breuning; Joop H Jansen
Journal:  Br J Haematol       Date:  2002-08       Impact factor: 6.998

7.  Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia.

Authors:  P Liu; S A Tarlé; A Hajra; D F Claxton; P Marlton; M Freedman; M J Siciliano; F S Collins
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

8.  Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia.

Authors:  D F Claxton; P Liu; H B Hsu; P Marlton; J Hester; F Collins; A B Deisseroth; J D Rowley; M J Siciliano
Journal:  Blood       Date:  1994-04-01       Impact factor: 22.113

9.  Detection of minimal residual disease in acute myelomonocytic leukemia with abnormal marrow eosinophils by nested polymerase chain reaction with allele specific amplification.

Authors:  J Hébert; J M Cayuela; M T Daniel; R Berger; F Sigaux
Journal:  Blood       Date:  1994-10-01       Impact factor: 22.113

10.  Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia.

Authors:  S A Shurtleff; S Meyers; S W Hiebert; S C Raimondi; D R Head; C L Willman; S Wolman; M L Slovak; A J Carroll; F Behm
Journal:  Blood       Date:  1995-06-15       Impact factor: 22.113

  10 in total
  1 in total

1.  Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case report.

Authors:  Wenyi Zhang; Hainan Wang; Peilei Zhang; Hongliang Li; Xiaoli Ma; Hongxing Liu
Journal:  Braz J Med Biol Res       Date:  2021-10-29       Impact factor: 2.590

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.